Redefining the origin and evolution of ovarian cancer: a hormonal connection.
@article{Cardenas2016RedefiningTO, title={Redefining the origin and evolution of ovarian cancer: a hormonal connection.}, author={Carlos Cardenas and Ayesha B. Alvero and Bo Seong Yun and Gil Mor}, journal={Endocrine-related cancer}, year={2016}, volume={23 9}, pages={ R411-22 } }
Ovarian cancer has the highest mortality of all female reproductive cancers. Late diagnosis, tumour heterogeneity and the development of chemoresistance contribute to this statistic and work against patient survival. Current studies have revealed novel concepts that impact our view on how ovarian cancer develops. The greatest impact is on our understanding that, as a disease, ovarian cancer has multiple cellular origins and that these malignant precursors are mostly derived from outside of the…
23 Citations
Ovarian Epithelial Carcinogenesis
- Biology, MedicineGynecologic and Obstetric Pathology, Volume 2
- 2019
The current chapter will focus on the cell origin, pathogenesis, molecular genetics, and clinical applications of different EOC histological subtypes to improve the understanding of this deadly disease.
Ovarian Cancer Stem Cell Heterogeneity.
- BiologyAdvances in experimental medicine and biology
- 2019
The particular clinical behavior of ovarian carcinoma strongly suggests an underlying stem cell component with a crucial impact, which becomes especially evident in high-grade serous ovarian carcinomas treated with classical chemotherapy, which entails a gradual evolution of chemoresistant disease without any apparent selection of clones carrying obvious chemoresistance-associated mutations.
Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype
- BiologyMedical Oncology
- 2020
Investigation of the effect of FSH on PGRN production in the CCOC cell line TOV-21G indicates that FSH induces P GRN expression and secretion only in CCOC cells.
CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary
- Medicine, BiologyCancers
- 2019
CD105 knockdown or blockade with a clinically relevant CD105-neutralizing mAb (TRC105), inhibited HGSC metastasis, reduced ascites, and impeded growth of abdominal tumor nodules, thereby improving overall survival in animal models of ovarian cancer.
CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress
- Biology, MedicineBMC Cancer
- 2019
Evaluated levels of ascites, serum and different tissues of ovarian cancer to explore the potential association of Cyr61 with the tumor-associated inflammatory microenvironment of EOC found significantly higher Cyr61 levels were found in ovarian serous cystadenocarcinoma and serum Cyr61 may be used as a potential marker for EOC inflammatory response.
Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
- BiologyCancers
- 2022
The relevant studies, which highlight the role of adipocytes in ovarian cancer progression and offer insights into unanswered questions and possible future directions of research are summarized.
Constructing an ovarian cancer metastasis index by dissecting medical records
- MedicineOncotarget
- 2017
Results indicated that ascites and laterality, rather than age and menopausal status, were the potential drivers for multi-organ metastasis, and a neural network cascade-multiple linear regression hybrid model was built to create an ovarian cancer metastasis index (OCMI), implying a potential prognostic marker for OC.
Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review
- BiologyReproductive Sciences
- 2018
It can be concluded that endocrine disruptors do have a potential carcinogenicity and their high proportions in human body may cause epigenetic modifications, prompting ovarian surface epithelium to grow in an abnormal manner.
References
SHOWING 1-10 OF 119 REFERENCES
The role of reproductive hormones in epithelial ovarian carcinogenesis.
- BiologyEndocrine-related cancer
- 2015
The role of reproductive hormones in influencing the immune system and tipping the balance against or in favor of developing ovarian cancer is discussed and comment on animal models that are critical for experimentally validating existing hypotheses in key areas of endocrine research and useful for preclinical drug development are commented on.
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- MedicineThe American journal of surgical pathology
- 2010
It has been proposed that serous tumors arise from the implantation of epithelium (benign or malignant) from the fallopian tube and preliminary data suggest that mucinous and transitional (Brenner) tumors arose from transitional-type epithelial nests at the tubal-mesothelial junction by a process of metaplasia.
Ovulation and extra-ovarian origin of ovarian cancer
- BiologyScientific Reports
- 2014
Experimental evidence is provided to support that ovulation, by disrupting the ovarian surface epithelium and releasing chemokines/cytokines, promotes the migration and adhesion of malignant cells to the ovary and the association between increased ovulation and the risk of ovarian cancer is supported.
Ovarian surface epithelium: biology, endocrinology, and pathology.
- MedicineEndocrine reviews
- 2001
The objective of this article is to review the cellular and molecular mechanisms that underlie the control of normal and neoplastic OSE cell growth, differentiation, and expression of indicators of neoplastics progression.
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention.
- MedicineAmerican journal of obstetrics and gynecology
- 2015
Ovarian cancer development and metastasis.
- Biology, MedicineThe American journal of pathology
- 2010
The initial steps of metastasis are regulated by a controlled interaction of adhesion receptors and proteases, and late metastasis is characterized by the oncogene-driven fast growth of tumor nodules on mesothelium covered surfaces, causing ascites, bowel obstruction, and tumor cachexia.
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
- Medicine, BiologyPloS one
- 2010
Combined molecular genetic and morphologic analyses of normal human ovarian tissues and early stage cancers indicate that EOC frequently arises in ovarian cystic inclusions, is preceded by an identifiable dysplastic precursor lesion, and that increased cell proliferation, decreased apoptosis, and aneuploidy are likely to represent very early aberrations in ovarian tumorigenesis.
Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?
- MedicineGynecologic oncology
- 2013
Ovarian Cancer
- BiologyBritish Journal of Cancer
- 1993
It is thought that the development of animal models in which ovarian cancer can be induced and studied during its early stages will enable better understanding of early ovarian cancer lesions and elucidate molecular events that support ovarian cancer progression.
Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.
- Biology, MedicineJournal of the National Cancer Institute
- 1983
Entrapment of surface epithelium within the ovarian stroma was proposed as an initial event in the pathogenesis of cystadenocarcinoma of the ovary and animal experiments suggested that gonadotropin excess and stromal stimulation may result by disturbing normal feedback inhibition between ovarian and pituitary or by destroying ovarian follicles.